Cargando…
Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy
Numerous in vivo studies have shown that the severe toxic side-effects of intravenously administered cisplatin can be significantly reduced by the co-administration of sulfur-containing ‘chemoprotective agents’. Using a metallomics approach, a likely biochemical basis for these potentially useful ob...
Autores principales: | Sooriyaarachchi, Melani, George, Graham N., Pickering, Ingrid J., Narendran, Aru, Gailer, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123636/ https://www.ncbi.nlm.nih.gov/pubmed/27722429 http://dx.doi.org/10.1039/c6mt00183a |
Ejemplares similares
-
Amygdalin as a chemoprotective agent in co-treatment with cisplatin
por: Christodoulou, Panayiota, et al.
Publicado: (2022) -
A pharmacokinetic–pharmacodynamic model for chemoprotective agents against malaria
por: Cherkaoui‐Rbati, Mohammed H., et al.
Publicado: (2022) -
Prophylactic efficacy of some chemoprotectants against abrin induced lethality
por: Saxena, Nandita, et al.
Publicado: (2018) -
A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy
por: Xiao, Qicai, et al.
Publicado: (2019) -
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
por: Petruzzella, Emanuele, et al.
Publicado: (2018)